A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for ...

Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...

The future depends on collaboration between pharma and diagnostics companies to implement strategies that accelerate innovation, ensure regulatory alignment, and deliver local access at global scale ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Tuberculosis is the world's deadliest infectious disease, but detecting it in remote and war-torn regions can be difficult. That's why some health clinics are now using AI to screen for the illness.

Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...

Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...